CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...

IRVINE, Calif. (CBS.MW) -- Shares of Allergan jumped 6 percent Monday after the specialty pharmaceutical company announced it won a highly anticipated regulatory approval to market its Botox drug as a ...

BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety ...

Concerns about eventual competition for Allergan Inc.’s cash cow Botox don’t seem to be weighing on the Irvine drug maker’s shares. For now, investors seem content with the company’s strong ...

Mylan and Revance Therapeutics announced plans to develop and commercialize a biosimilar to Allergan’s Botox, TheStreet reports. Here’s what you should know. 1. Market analysts believe the deal puts ...

NEW YORK, May 1 (Reuters) - Allergan Inc said first-quarter earnings fell by more than half as sales of its Botox anti-wrinkle drug and its medical devices fell, sending the company's shares down 6.2 ...

The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to ...

Dermatologists have been jumping on the bandwagon to accommodate aging Baby Boomers, so it shouldn't come as a surprise that Botox injections were the single most popular non-invasive cosmetic ...

The U.S. Food and Drug Administration has chastised Allergan for what it called "misleading" advertising for popular anti-wrinkle drug Botox. Among other things, the agency said the ads fail to ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...